Our research finds that Life Sciences CEOs are confident in industry growth fuelled by innovation, technological advancement, and operational efficiency.
There is a strong appetite for mergers and acquisitions, substantial investments in AI and digitalisation, and a critical need to empower the workforce to navigate rapid change. While sustainability and ESG remain high on the agenda for Life Sciences organisations globally, there are shifting priorities across regions.
By downloading the 2025 Life Sciences CEO Outlook, you’ll unlock unique perspectives on:
Enhance your strategic planning with expert analysis and actionable insights.
Unlock the potential within your organisation with insights from our latest Life Sciences CEO Outlook.
At KPMG, we understand the unique challenges and opportunities in the life sciences sector. Whether you need strategic advice, regulatory support, or growth strategies, our experts are ready to assist.
Contact Brian Egan of our Life Sciences team for an initial conversation; we'd be delighted to hear from you.
